KOÇYİĞİT, D. Et Al. 2017. Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.17, no.1 , 19-31.

KOÇYİĞİT, D., Gurses, K. M., YALÇIN, M. U., & Tokgozoglu, L., (2017). Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.17, no.1, 19-31.

KOÇYİĞİT, DUYGU Et Al. "Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade," ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.17, no.1, 19-31, 2017

KOÇYİĞİT, DUYGU Et Al. "Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade." ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.17, no.1, pp.19-31, 2017

KOÇYİĞİT, D. Et Al. (2017) . "Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade." ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , vol.17, no.1, pp.19-31.

@article{article, author={DUYGU KOÇYİĞİT Et Al. }, title={Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade}, journal={ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS}, year=2017, pages={19-31} }